Le Lézard
Classified in: Health, Business
Subjects: MAV, LBR, AVO

Media Advisory - ONA President Cathryn Hoy, RN, available for comment following her meeting with Premier Ford


TORONTO, Feb. 2, 2022 /CNW/ - The Ontario Nurses' Association is hopeful its much-anticipated meeting with Premier Doug Ford and Minister of Health Christine Elliott could set the stage for needed solutions to address the nursing and health professional crisis plaguing Ontario's health-care system.

Nurses and health professionals have faced a tumultuous and chaotic work environment for more than a decade, and the pandemic has exacerbated and exposed the system's frailty. Patients, residents and clients have been deeply impacted by the ongoing nursing crisis, while more nurses are being driven away by excessive workloads and overtime, dangerous conditions, and legislation that has suppressed their wages and overridden collective agreements.

ONA President Cathryn Hoy, RN, First Vice-President Angela Preocanin, RN, are meeting with Premier Ford and Minister Elliott on Thursday afternoon to present solutions to the nursing shortage and to ask for urgent action. Hoy will be available later that afternoon for media interviews.

WHAT: 

ONA President Cathryn Hoy, RN, available for media interviews

WHEN:  

After 3 p.m. on Thursday, February 3, 2022.

WHY:    

To discuss the result of the meeting and to outline next steps.

www.ona.org; Facebook.com/OntarioNurses; Twitter.com/OntarioNurses; instagram.com/ontario.nurses

SOURCE Ontario Nurses' Association


These press releases may also interest you

at 05:09
Sectra publishes Annual Report and Sustainability Report for 2023/2024
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period. The...

at 03:20
Launch of Phase 3 clinical trial with Nefecon in Japan
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
India-Based Dhiti Omics is Now Live on SOPHiA DDMtm
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech Provides Update on Phase II/III SKYSCRAPER-06 Study in Metastatic Non-Squamous Non-Small Cell Lung Cancer
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI: Appointment of Adviser
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

More news about Health...


News published on and distributed by: